Annual CFO:
-$348.88M+$45.21M(+11.47%)Summary
- As of today, NTLA annual cash from operations is -$348.88 million, with the most recent change of +$45.21 million (+11.47%) on December 31, 2024.
- During the last 3 years, NTLA annual cash from operations has fallen by -$123.85 million (-55.04%).
- NTLA annual cash from operations is now -1066.19% below its all-time high of $36.11 million, reached on December 31, 2016.
Performance
NTLA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$76.90M+$22.72M(+22.81%)Summary
- As of today, NTLA quarterly cash from operations is -$76.90 million, with the most recent change of +$22.72 million (+22.81%) on September 30, 2025.
- Over the past year, NTLA quarterly cash from operations has increased by +$7.94 million (+9.36%).
- NTLA quarterly cash from operations is now -213.84% below its all-time high of $67.55 million, reached on June 30, 2016.
Performance
NTLA Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$410.65M+$7.94M(+1.90%)Summary
- As of today, NTLA TTM cash from operations is -$410.65 million, with the most recent change of +$7.94 million (+1.90%) on September 30, 2025.
- Over the past year, NTLA TTM cash from operations has dropped by -$53.91 million (-15.11%).
- NTLA TTM cash from operations is now -931.76% below its all-time high of $49.37 million, reached on June 30, 2016.
Performance
NTLA TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NTLA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +11.5% | +9.4% | -15.1% |
| 3Y3 Years | -55.0% | +2.1% | -37.8% |
| 5Y5 Years | -237.9% | -169.3% | -970.8% |
NTLA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -55.0% | +11.5% | -32.2% | +48.4% | -37.8% | +1.9% |
| 5Y | 5-Year | -599.0% | +11.5% | -169.3% | +48.4% | -970.8% | +1.9% |
| All-Time | All-Time | -1066.2% | +11.5% | -213.8% | +48.4% | -931.8% | +1.9% |
NTLA Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$76.90M(+22.8%) | -$410.65M(+1.9%) |
| Jun 2025 | - | -$99.62M(+33.1%) | -$418.58M(-11.0%) |
| Mar 2025 | - | -$148.93M(-74.8%) | -$377.15M(-8.1%) |
| Dec 2024 | -$348.88M(+11.5%) | -$85.19M(-0.4%) | -$348.88M(+2.2%) |
| Sep 2024 | - | -$84.84M(-45.8%) | -$356.74M(+4.4%) |
| Jun 2024 | - | -$58.19M(+51.8%) | -$373.28M(+7.9%) |
| Mar 2024 | - | -$120.66M(-29.7%) | -$405.42M(-2.9%) |
| Dec 2023 | -$394.09M(-18.2%) | -$93.05M(+8.2%) | -$394.09M(-0.8%) |
| Sep 2023 | - | -$101.38M(-12.2%) | -$390.90M(-6.2%) |
| Jun 2023 | - | -$90.32M(+17.4%) | -$368.05M(-1.4%) |
| Mar 2023 | - | -$109.33M(-21.7%) | -$362.81M(-8.9%) |
| Dec 2022 | -$333.29M(-48.1%) | -$89.87M(-14.4%) | -$333.29M(-11.8%) |
| Sep 2022 | - | -$78.53M(+7.7%) | -$298.07M(-4.7%) |
| Jun 2022 | - | -$85.09M(-6.6%) | -$284.56M(-12.7%) |
| Mar 2022 | - | -$79.80M(-46.0%) | -$252.46M(-12.2%) |
| Dec 2021 | -$225.03M(-350.9%) | -$54.65M(+15.9%) | -$225.03M(-6.8%) |
| Sep 2021 | - | -$65.02M(-22.7%) | -$210.60M(-20.9%) |
| Jun 2021 | - | -$52.98M(-1.2%) | -$174.14M(-173.2%) |
| Mar 2021 | - | -$52.38M(-30.2%) | -$63.74M(-27.7%) |
| Dec 2020 | -$49.91M | -$40.23M(-40.9%) | -$49.91M(-30.2%) |
| Sep 2020 | - | -$28.56M(-149.7%) | -$38.35M(-8.8%) |
| Jun 2020 | - | $57.42M(+249.0%) | -$35.24M(+70.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$38.55M(-34.5%) | -$120.33M(-16.6%) |
| Dec 2019 | -$103.24M(-68.5%) | -$28.66M(-12.6%) | -$103.24M(-24.2%) |
| Sep 2019 | - | -$25.45M(+8.1%) | -$83.12M(-18.5%) |
| Jun 2019 | - | -$27.68M(-29.0%) | -$70.12M(-8.0%) |
| Mar 2019 | - | -$21.45M(-151.3%) | -$64.94M(-6.0%) |
| Dec 2018 | -$61.26M(+6.2%) | -$8.54M(+31.4%) | -$61.26M(+17.2%) |
| Sep 2018 | - | -$12.45M(+44.6%) | -$74.03M(+5.7%) |
| Jun 2018 | - | -$22.50M(-26.6%) | -$78.47M(-9.5%) |
| Mar 2018 | - | -$17.77M(+16.6%) | -$71.65M(-9.8%) |
| Dec 2017 | -$65.28M(-280.8%) | -$21.31M(-26.1%) | -$65.28M(-11.8%) |
| Sep 2017 | - | -$16.89M(-7.8%) | -$58.38M(-18.9%) |
| Jun 2017 | - | -$15.68M(-37.6%) | -$49.10M(-243.8%) |
| Mar 2017 | - | -$11.40M(+20.9%) | $34.13M(-5.5%) |
| Dec 2016 | $36.11M(+2148.2%) | -$14.41M(-89.4%) | $36.11M(-19.8%) |
| Sep 2016 | - | -$7.61M(-111.3%) | $45.03M(-8.8%) |
| Jun 2016 | - | $67.55M(+817.0%) | $49.37M(+408.5%) |
| Mar 2016 | - | -$9.42M(-71.6%) | -$16.01M(-807.9%) |
| Dec 2015 | -$1.76M(+24.1%) | -$5.49M(-68.1%) | -$1.76M(-147.3%) |
| Sep 2015 | - | -$3.27M(-250.3%) | $3.73M(-46.7%) |
| Jun 2015 | - | $2.17M(-54.9%) | $7.00M(+45.1%) |
| Mar 2015 | - | $4.82M | $4.82M |
| Dec 2014 | -$2.32M | - | - |
FAQ
- What is Intellia Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Intellia Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Intellia Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of NTLA is -$348.88M
What is the all-time high annual cash from operations for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual cash from operations is $36.11M
What is Intellia Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, NTLA annual cash from operations has changed by +$45.21M (+11.47%)
What is Intellia Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of NTLA is -$76.90M
What is the all-time high quarterly cash from operations for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly cash from operations is $67.55M
What is Intellia Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, NTLA quarterly cash from operations has changed by +$7.94M (+9.36%)
What is Intellia Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of NTLA is -$410.65M
What is the all-time high TTM cash from operations for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high TTM cash from operations is $49.37M
What is Intellia Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, NTLA TTM cash from operations has changed by -$53.91M (-15.11%)